Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
To increase the plasma half-life, a slower-releasing formula of exenatide was developed by incorporating to a polymer microsphere, permitting a once-weekly injection
The primary and secondary outcome endpoints of MACE and nonfatal stroke demonstrated significant reductions in the dulaglutide-treated REWIND trial and the subcutaneous semaglutide-treated SUSTAIN-6 study [41]
The conjugation of dopamine or ibuprofen to the non-targeted or A-GSH functionalized nanocarriers did not affect the impedance kinetics of brain endothelial cells (Figs
Amber vials or foil-wrapped storage reduces UV exposure during handling and transit
